Biote [BTMD] vs HCA Healthcare [HCA] Detailed Stock Comparison

Biote Corp.

NASDAQ
Loading...

HCA Healthcare Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Biote Corp. wins in 11 metrics, HCA Healthcare Inc. wins in 9 metrics, with 0 ties. Biote Corp. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Biote Corp. HCA Healthcare Inc. Better
P/E Ratio (TTM) 3.08 16.86 Biote Corp.
Price-to-Book Ratio -1.39 -38.44 Biote Corp.
Debt-to-Equity Ratio -2.18 -17.57 Biote Corp.
PEG Ratio -0.06 0.37 HCA Healthcare Inc.
EV/EBITDA 4.37 10.08 Biote Corp.
Profit Margin (TTM) 14.07% 8.97% Biote Corp.
Operating Margin (TTM) 9.40% 16.29% HCA Healthcare Inc.
EBITDA Margin (TTM) 9.40% 16.29% HCA Healthcare Inc.
Return on Equity -53.66% -244.82% Biote Corp.
Return on Assets (TTM) 19.06% 12.44% Biote Corp.
Free Cash Flow (TTM) $28.33M $7.69B HCA Healthcare Inc.
Dividend Yield N/A 0.59% N/A
1-Year Return -34.92% 4.31% HCA Healthcare Inc.
Price-to-Sales Ratio (TTM) 0.38 1.39 Biote Corp.
Enterprise Value $163.97M $156.18B HCA Healthcare Inc.
EV/Revenue Ratio 0.85 2.07 Biote Corp.
Gross Profit Margin (TTM) 68.03% 41.90% Biote Corp.
Revenue per Share (TTM) $6 $320 HCA Healthcare Inc.
Earnings per Share (Diluted) $0.74 $27.94 HCA Healthcare Inc.
Beta (Stock Volatility) 1.29 1.37 Biote Corp.
Short % of Float 7.11% 2.45% HCA Healthcare Inc.

Biote Corp. vs HCA Healthcare Inc. Stock Performance Analysis

Loading Price Chart...

BTMD
HCA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Biote Corp.-8.54%-3.85%14.21%63.04%-14.12%-8.91%
HCA Healthcare Inc.0.72%7.93%-7.81%-25.75%-18.24%-17.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Biote Corp.-34.92%-58.66%-75.15%-75.52%-75.52%-75.52%
HCA Healthcare Inc.4.31%33.47%92.28%400.04%1,019.34%1,144.15%

Performance & Financial Health Analysis: Biote Corp. vs HCA Healthcare Inc.

MetricBTMDHCA
Market Information
Market Cap i$84.97M$106.00B
Market Cap CategoryMicro capLarge cap
10 Day Avg. Volume i231,770795,641
90 Day Avg. Volume i321,103974,074
Last Close$2.25$389.97
52 Week Range$1.27 - $4.75$330.00 - $556.52
% from 52W High-52.63%-29.93%
All-Time High$10.52 (May 23, 2022)$556.52 (Mar 12, 2026)
% from All-Time High-78.61%-29.93%
Growth Metrics
Quarterly Revenue Growth-0.07%0.07%
Quarterly Earnings Growth-0.47%0.31%
Financial Health
Profit Margin (TTM) i0.14%0.09%
Operating Margin (TTM) i0.09%0.16%
Return on Equity (TTM) i-0.54%-2.45%
Debt to Equity (MRQ) i-2.18-17.57
Cash & Liquidity
Book Value per Share (MRQ)$-1.91$-26.83
Cash per Share (MRQ)$0.79$5.11
Operating Cash Flow (TTM) i$35.19M$12.64B
Levered Free Cash Flow (TTM) i$13.27M$5.82B
Dividends
Last 12-Month Dividend Yield iN/A0.59%
Last 12-Month Dividend iN/A$2.94

Valuation & Enterprise Metrics Analysis: Biote Corp. vs HCA Healthcare Inc.

MetricBTMD (Apr 26, 2026)HCA (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i3.0816.86
Forward P/E i4.0014.13
PEG Ratio i-0.060.37
Price to Sales (TTM) i0.381.39
Price to Book (MRQ) i-1.39-38.44
Market Capitalization
Market Capitalization i$84.97M$106.00B
Enterprise Value i$163.97M$156.18B
Enterprise Value Metrics
Enterprise to Revenue i0.852.07
Enterprise to EBITDA i4.3710.08
Risk & Other Metrics
Beta i1.291.37
Book Value per Share (MRQ) i$-1.91$-26.83

Financial Statements Comparison: Biote Corp. vs HCA Healthcare Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBTMD (2025)HCA (2025)
Revenue/Sales i192.22M75.60B
Cost of Goods Sold i54.86M44.23B
COGS % of Revenue i28.5%58.5%
Gross Profit i137.36M31.37B
Gross Margin i71.5%41.5%
Research & Development iN/AN/A
Operating Income (EBIT) i35.55M11.97B
Operating Margin i18.5%15.8%
EBITDA i39.19M15.57B
EBITDA Margin i20.4%20.6%
Pre-Tax Income i37.58M9.83B
Pre-Tax Income % of Revenue i19.6%13.0%
Income Tax i5.99M2.05B
Income Tax % of Revenue i3.1%2.7%
Net Income (Profit) i31.60M7.78B
Profit Margin i16.4%10.3%

Balance Sheet & Liquidity Metrics

MetricBTMD (2025)HCA (2025)
Cash & Equivalents i24.12M1.04B
Total Current Assets i54.67M15.78B
Total Current Assets % of Revenue i28.4%20.9%
Total Current Liabilities i44.99M16.35B
Total Current Liabilities % of Revenue i23.4%21.6%
Long-Term Debt i103.08M43.46B
Long-Term Debt % of Revenue i53.6%57.5%
Total Shareholders Equity i-50.40M-2.77B
Retained Earnings i-49.55M-5.72B
Retained Earnings % of Revenue i-25.8%-7.6%
Property, Plant & Equipment i1.69M39.12B

Cash Flow Statement Comparison

MetricBTMD (2025)HCA (2025)
Operating Cash Flow i34.19M12.01B
Operating Cash Flow % of Revenue i17.8%15.9%
Capital Expenditures i-5.02M-4.94B
Free Cash Flow i28.33M7.69B
FCF Margin i14.7%10.2%
Debt Repayment i-6.25M-7.39B
Common Stock Repurchase i-3.37M-10.07B

Short Interest & Institutional Ownership Analysis

MetricBTMDHCA
Shares Short i1.69M3.63M
Short Ratio i4.813.37
Short % of Float i7.11%2.45%
Shares Outstanding i30.71M224.61M
Float Shares i20.26M151.19M
% Held by Insiders i9.77%16.16%
% Held by Institutions i64.32%78.70%
% Held by Public i25.91%5.14%

Dividend Analysis & Yield Comparison: Biote Corp. vs HCA Healthcare Inc.

MetricBTMDHCA
Last 12-Month Dividend iN/A$2.94
Last 12-Month Dividend Yield iN/A0.59%
3-Year Avg Annual Dividend iN/A$2.70
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$8.10
Ex-Dividend DateN/AMar 17, 2026